Mercury Bio
Santa Fe
About Mercury Bio
Mercury Bio is a biomolecular delivery platform that transforms and treats viral diseases, cancer, and inflammatory conditions. Its platform delivers natural-like RNA molecules to specific cells and organs and destroys the virus's RNA, without affecting the human genes, blocking further replication and spread of the virus while enhancing the production of essential hormones such as insulin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.8M
- Last round: Series Unknown (Oct 2025)
- Website: mercurybio.com
- Phone: +1 (800) 274-8533
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Canonical: https://fsome.com/organization/mercury-bio-81766 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.